✦ LIBER ✦

Efficacy and safety of 0.8 mg dosage of cerivastatin, a novel HMG-CoA reductase inhibitor

✍ Scribed by Stein, E.; Isaacsohn, J.; Stoltz, R.; Mazzu, A.; Liu, M.-C.; Lane, C.; Heller, A.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical safety evaluation of cerivas

✍ Eckhard von Keutz; Gerhard Schlüter 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Pitavastatin: Efficacy and Safety Profil

✍ Kajinami, Kouji ;Takekoshi, Noboru ;Saito, Yasushi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Cerivastatin: pharmacology of a novel sy

✍ Hilmar Bischoff; Rolf Angerbauer; Joachim Bender; Erwin Bischoff; Agostino Faggi 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 224 KB

2.P.59 Efficacy and safety of cerivastat

✍ L.A. Leiter 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 362 KB

2.P.64 Biopharmaceutical profile of ceri

✍ W. Mück; K. Ochmann; A. Mazzu; J. Lettieri 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 180 KB

In vitro antitumor activity of cerivasta

✍ Wojciech Feleszko; Izabela Mlynarczuk; Dominika Nowis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 54 KB